21st Annual Osteoporosis: New Insights in Research, Diagnosis, and Clinical Care - Live Stream

Osteoporosis 2024
Live Stream: July 25, 2024
Course# MEP25001

Need Help?

Register Today!

July 25, 2024
Live Stream
Course# MEP25001

Department: Epidemiology and Biostatistics


Registration Fees

$400     Physicians

$350     Allied Health Professionals

$300     Residents/Fellows

Cancellation Policy

Cancellations received in writing before July 18, 2024 will be refunded, less an administrative fee of $75. No refunds will be made on cancellations received after that date.

Please email your requests to [email protected]



Now in its 21st year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The course will critically review current treatment options. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis.
The course will provide an update on current recommendations about screening and treatment of osteoporosis for physicians and other clinicians working with osteoporosis patients. It will also benefit researchers, technologists, and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. No prior clinical or scientific training in osteoporosis is required.

Live Stream Meeting
This course will be offered as a virtual conference. Login instructions along with the digital syllabus will be shared with the attendees a week before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.



  • Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
  • Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
  • Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
  • Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
  • Understand the evidence for vitamin D in the optimization of bone health;
  • Recognize racial differences and disparities in osteoporosis care.


In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Course Outline

Coming Soon!


Course Chairs

Dennis M. Black, PhD
Professor of Epidemiology and Biostatistics

Anne L. Schafer, MD
Professor of Medicine and of Epidemiology & Biostatistics, UCSF;
Endocrine Research Unit, San Francisco VA Medical Center


SF Pyramid


(University of California, San Francisco unless indicated)

Coming Soon!





Travel & Lodging

Live Stream Meeting